Table 3.
Immunohistochemistry
Case | Pan-CK | EMA | p63 | ASMA | S100 | GFAP | Calponin |
---|---|---|---|---|---|---|---|
MEC | |||||||
1 | − | + | − | f + | − | nd | + |
2 | + | nd | − | f + | f + | − | f + |
3 | f + | nd | − | f + | − | nd | f + |
4 | − | + | − | f + | − | − | nd |
5 | f + | − | nd | f+ | − | nd | nd |
6 | + | nd | + | + | − | nd | nd |
7 | + | + | − | − | f + | − | − |
8 | + | − | nd | nd | + | − | + |
9 | + | − | − | − | f+ | nd | − |
10 | + | + | + | nd | f+ | nd | nd |
8/10 | 4/7 | 2/8 | 6/8 | 5/10 | 0/4 | 4/6 | |
80 % | 57 % | 25 % | 75 % | 50 % | 0 % | 67 % | |
EMC | |||||||
11 | − | − | + | f + | f + | f+ | nd |
12 | − | − | − | − | f + | − | nd |
13 | − | f+ | nd | − | − | − | nd |
14 | − | − | − | − | − | − | nd |
15 | − | f + | − | − | − | − | nd |
0/5 | 2/5 | 1/4 | 1/5 | 2/5 | 1/5 | ||
0 % | 40 % | 25 % | 20 % | 40 % | 20 % |
f focally, nd not done